Search by Drug Name or NDC
NDC 59917-0102-01 POTASSIUM CHLORIDE 600 mg/1 Details
POTASSIUM CHLORIDE 600 mg/1
POTASSIUM CHLORIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Adare Pharmaceuticals Inc. The primary component is POTASSIUM CHLORIDE.
MedlinePlus Drug Summary
Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney disease and gastrointestinal disease with vomiting and diarrhea) and drugs, especially diuretics ('water pills'), remove potassium from the body. Potassium supplements are taken to replace potassium losses and prevent potassium deficiency. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 59917-0102-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Potassium
Product Information
| NDC | 59917-0102 |
|---|---|
| Product ID | 59917-102_0cf861f5-7a8c-9ba4-e063-6294a90a601f |
| Associated GPIs | 79700030000205 |
| GCN Sequence Number | 001249 |
| GCN Sequence Number Description | potassium chloride CAPSULE ER 8 MEQ ORAL |
| HIC3 | C1D |
| HIC3 Description | POTASSIUM REPLACEMENT |
| GCN | 03320 |
| HICL Sequence Number | 000549 |
| HICL Sequence Number Description | POTASSIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | POTASSIUM CHLORIDE |
| Proprietary Name Suffix | EXTENDED RELEASE |
| Non-Proprietary Name | POTASSIUM CHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 600 |
| Active Ingredient Units | mg/1 |
| Substance Name | POTASSIUM CHLORIDE |
| Labeler Name | Adare Pharmaceuticals Inc |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208864 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59917-0102-01 (59917010201)
| NDC Package Code | 59917-102-01 |
|---|---|
| Billing NDC | 59917010201 |
| Package | 100 CAPSULE in 1 BOTTLE, PLASTIC (59917-102-01) / 1 CAPSULE in 1 CAPSULE |
| Marketing Start Date | 2018-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.11695 |
| Pricing Unit | EA |
| Effective Date | 2022-11-23 |
| NDC Description | POTASSIUM CL ER 8 MEQ CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis